Skip to main content

Table 2 Characteristics of patients with JIA-associated uveitis

From: Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER

Patient Characteristics

 

Patients, n (%)

34 (6.8)

Sex, female, n (%)

20 (58.8)

Duration between onset of arthritis and uveitis, years, mean ± SD

1.8 ± 1.9

 oJIA

1.9 ± 1.8

 ERA

1.7 ± 2.1

 Poly JIA, RF–

1.8 ± 3.0

Onset of uveitis after JIA diagnosis,a years, n (%)

 0–1

13 (38.2)

 1–2

4 (11.8)

 2–3

5 (14.7)

  > 3

9 (26.5)

Affected eye,b n (%)

 Right only

5 (17.2)

 Left only

8 (27.6)

 Both

16 (55.2)

Localization of uveitis,c n (%)

 Anterior

19 (76)

 Intermediate

2 (8)

 Posterior

2 (8)

 Panuveitis

2 (8)

Categories of JIA/sex distribution, n (%) [female % within n]

 oJIA

25 (73.5) [64]

 poJIA

20 (58.8) [65]

 eoJIA

5 (14.7) [60]

 ERA

6 (17.7) [9]

 Poly JIA, RF–

3 (8.8) [100]

ANA positivity, n/N (%)

22/34 (64.7)

HLA-B27 positivity, n/N (%)

3/10 (30)

Systemic treatments initiated after the diagnosis of uveitis, n (%)

 Methotrexate

6 (17.6)

 Azathioprine

4 (11.8)

 Sulfasalazine

4 (11.8)

 TNF-alpha inhibitors

13 (38.2)

 Tocilizumab

3 (8.8)

Complications, n (%)

5 (14.7)

 Cataract

4 (11.8)

 Band keratopathy

1 (2.9)

  1. ANA antinuclear antibody, eoJIA extended oJIA, ERA enthesitis-related arthritis, HLA human leucocyte antigen, JIA juvenile idiopathic arthritis, oJIA oligoarticular JIA, poJIA persistent oJIA, Poly JIA polyarticular JIA, RF rheumatoid factor, TNF tumor necrosis factor
  2. a The diagnosis of uveitis preceded the diagnosis of JIA in 3 patients
  3. b There were no data available for 5 patents
  4. c There were no data available for 9 patients